Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06307977 · ClinicalTrials.gov registry record · NA
Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples
A NA study of HIV Infections and Substance Use, sponsored by Hunter College of City University of New York.
- Recruiting
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 3
- Study locations
NCT06307977: Recruiting NA study of HIV Infections and Substance Use, sponsored by Hunter College of City University of New York.
NCT06307977 is a NA study of HIV Infections and Substance Use that is actively recruiting participants, run by Hunter College of City University of New York. The registered enrollment target is 360 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (19% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06307977, a NA study of HIV Infections and Substance Use, is actively recruiting participants, sponsored by Hunter College of City University of New York.
- RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study utilizes a randomized controlled trial design to evaluate the efficacy of couples motivational interviewing (MI) to reduce the frequency and severity of illicit drug use and frequency of HIV transmission risk behavior (TRB). Participants are randomized to one of two conditions: couples MI or standard couples HIV testing and counseling (CHTC).
Primary Outcome
Number of reported days of illicit drug use (amphetamines, cocaine/crack, GHB, ketamine or ecstasy) reported on quarterly timeline follow-back assessments
Conditions Studied
Interventions
- BEHAVIORAL Couples Health Project
Study Locations (3)
Michigan
- Wayne State University - Detroit
New York
- Hunter College - New York
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2024-05-25 |
| Est. Completion | 2029-02 |
| Phase | NA |
What NCT06307977 shows while recruiting
NCT06307977 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (19% lower).
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Couples Health Project is the first listed.
NCT06307977 reports a single indexed study location in Michigan, New York, Virginia.
Frequently Asked Questions
What is clinical trial NCT06307977 about?
NCT06307977 is a clinical study titled "Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples". This study utilizes a randomized controlled trial design to evaluate the efficacy of couples motivational interviewing (MI) to reduce the frequency and severity of illicit drug use and frequency of HIV transmission risk behavior (TRB). Participants are randomized to one of two conditions: couples MI...
What is the current status of trial NCT06307977?
This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2024-05-25. Estimated completion is 2029-02.
What conditions does trial NCT06307977 study?
This clinical trial studies the following conditions: HIV Infections, Substance Use.
What interventions are being tested in trial NCT06307977?
The interventions under investigation include: Couples Health Project (BEHAVIORAL).
Who is sponsoring clinical trial NCT06307977?
This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06307977 being conducted?
This trial has 3 study locations across Michigan, New York, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06307977's enrollment target sits among peer trials
360 94th of 542 higher than 446 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI